Patents by Inventor Sylvian Gabriel Goutebroze

Sylvian Gabriel Goutebroze has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inactivated vaccine against feline calicivirosis
    Patent number: 7029682
    Abstract: Immunogenic preparations and vaccines, in particular which are inactivated, effective against feline calicivirosis, based on an FCV virus strain 431 as deposited at the CNCM under the accession number CNCM I-2166, or one of its equivalents, in a veterinarily acceptable vehicle or excipient, preferably combined with FCV virus obtained from another FCV strain, in particular strain G1 as deposited at the CNCM under the accession number CNCM I-2167.
    Type: Grant
    Filed: February 18, 2003
    Date of Patent: April 18, 2006
    Assignee: Merial
    Inventors: Herve Poulet, Sylvian Gabriel Goutebroze
  • Inactivated vaccine against feline calicivirosis
    Publication number: 20040076644
    Abstract: Immunogenic preparations and vaccines, in particular which are inactivated, effective against feline calicivirosis, based on an FCV virus strain 431 as deposited at the CNCM under the accession number CNCM I-2166, or one of its equivalents, in a veterinarily acceptable vehicle or excipient, preferably combined with FCV virus obtained from another FCV strain, in particular strain G1 as deposited at the CNCM under the accession number CNCM I-2167.
    Type: Application
    Filed: February 18, 2003
    Publication date: April 22, 2004
    Inventors: Herve Poulet, Sylvian Gabriel Goutebroze
  • Inactivated vaccine against feline calicivirosis
    Patent number: 6534066
    Abstract: Immunogenic preparations and vaccines, in particular which are inactivated, effective against feline calicivirosis, based on an FCV virus strain 431 as deposited at the CNCM under the accession number CNCM I-2166, or one of its equivalents, in a veterinarily acceptable vehicle or excipient, preferably combined with FCV virus obtained from another FCV strain, in particular strain G1 as deposited at the CNCM under the accession number CNCM I-2167.
    Type: Grant
    Filed: July 14, 2000
    Date of Patent: March 18, 2003
    Assignee: Merial
    Inventors: Herve Poulet, Sylvian Gabriel Goutebroze